A faculty member since 1994, Chandrakasan has also served as dean of engineering and MIT’s inaugural chief innovation and strategy officer, among other roles.
The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.